Bristol myers squibb receives positive chmp opinion for car t cell therapy breyanzi for relapsed or refractory follicular lymphoma

Princeton, n.j.--(business wire)---- $bmy #breyanzi--bristol myers squibb receives positive chmp opinion for car t cell therapy breyanzi for relapsed or refractory follicular lymphoma.
CAR Ratings Summary
CAR Quant Ranking